Tonix Pharmaceuticals Holding (TNXP) Current Assets (2010 - 2026)

Tonix Pharmaceuticals Holding's Current Assets history runs 17 years deep, the most recent figure standing at $207.2 million for Q1 2026.

• On a quarterly basis, Current Assets rose 38.51% year-over-year to $207.2 million in Q1 2026; TTM through Mar 2026 was $207.2 million, a 38.51% increase from a year earlier, with the FY2025 full-year figure at $228.9 million, up 92.33% from the prior year.
• Current Assets slipped to $207.2 million in Q1 2026 per TNXP's latest filing, from $228.9 million in the prior quarter.
• Across five years, Current Assets topped out at $228.9 million in Q4 2025 and bottomed at $25.3 million in Q2 2024.
• The 5-year median for Current Assets is $130.8 million (2022), against an average of $117.8 million.
• Across the five-year window, Current Assets tumbled 79.27% in 2023 and soared 467.62% in 2025, its largest moves.
• Year by year, Current Assets stood at $130.8 million in 2022, then tumbled by 63.47% to $47.8 million in 2023, then jumped by 149.12% to $119.0 million in 2024, then jumped by 92.33% to $228.9 million in 2025, then retreated by 9.48% to $207.2 million in 2026.
• Per Business Quant, the three latest TNXP Current Assets figures stand at $207.2 million (Q1 2026), $228.9 million (Q4 2025), and $208.1 million (Q3 2025).